| Literature DB >> 20010160 |
Saurabh Sethi1, Nishant Tageja, Jatinder Singh, Haitham Arabi, Maneesh Dave, Apurva Badheka, Sanjay Revankar.
Abstract
Fibrolamellar carcinoma (FLC) is a rare malignant hepatocellular tumor of unknown etiology, arising almost exclusively from noninfected, noncirrhotic liver of young adults. FLC has traditionally been considered to have better survival than hepatocellular carcinoma; however, this notion might be highly erroneous. Patients with metastatic disease at presentation have a dismal prognosis with 5-year survival of only 15%. We describe a case of highly aggressive metastatic FLC that presented as hyperammonemic encephalopathy, which has never been previously reported in the literature.Entities:
Mesh:
Year: 2009 PMID: 20010160 DOI: 10.1097/MAJ.0b013e3181bccfb4
Source DB: PubMed Journal: Am J Med Sci ISSN: 0002-9629 Impact factor: 2.378